Renal Function and Outcomes in Anticoagulated Patients With Non-Valvular Atrial Fibrillation: The AMADEUS Trial

Study Questions:

What is the impact of renal function on systemic embolism and bleeding in patients with atrial fibrillation (AF) on anticoagulation, and what is the additive prognostic value of moderate-severe chronic kidney disease (CKD) on CHADS2 and CHA2DS2VASc?